APA (7th ed.) Citation

M, M., N, M., X, P., S, C., C, T., K, S., . . . C, M. (2026). Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report. Pharmaceutics, 18(5), . https://doi.org/10.3390/pharmaceutics18050566

Chicago Style (17th ed.) Citation

M, McAllister, et al. "Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report." Pharmaceutics 18, no. 5 (2026). https://doi.org/10.3390/pharmaceutics18050566.

MLA (9th ed.) Citation

M, McAllister, et al. "Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report." Pharmaceutics, vol. 18, no. 5, 2026, https://doi.org/10.3390/pharmaceutics18050566.